Diligence memo · auto-generated · as of July 3, 2026

Seno Medical Instruments, Inc

Seno Medical Instruments, Inc looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Seno Medical Instruments, Inc operates in Other Health Care, based in SAN ANTONIO.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Seno Medical Instruments, Inc has raised $63M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $30M on 2013-12-31.

Most recent recorded round closed around 2013-12-31.

Valuation (modeled)modeled

Provath models Seno Medical Instruments, Inc at approximately $674M (range $71M–$2.6B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.52× the median modeled value of Series B Other Health Care companies in 2013–2015 (85 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 14 months.

Last raise 12.5 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 4.1× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 94% of Other Health Care peers (5377 compared).

Modeled value ranks above 95% of those peers.

Closest niche peers: Drynachan, Llc, Vistria SHC Holdings, LLC, Ebh Holding Company, Inc., Orthopediatrics Corp, Assurerx Health, Inc.

Peoplefiled

18 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.